Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$18,025,979
+$1,779,042 QoQ
Shares Held
71,634
-4.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#661
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $157,042,184 across 12 Drug Manufacturers - General names. ABBV ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,791 | $60,920,254 | |
| 2 | JNJ |
Johnson & Johnson
|
184,823 | $46,939,497 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
71,634 | $18,025,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,736 | $12,173,576 | |
| 5 | NVS |
Novartis AG
|
29,237 | $4,582,022 | |
| 6 | AMGN |
Amgen Inc
|
12,190 | $4,414,242 | |
| 7 | PFE |
Pfizer Inc
|
142,810 | $3,438,864 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
42,788 | $2,465,444 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,025,979 | 71,634 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $16,246,937 | 74,702 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $16,317,384 | 71,414 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $18,045,996 | 77,939 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,271,579 | 76,886 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,394,652 | 68,703 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,757,438 | 71,792 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $13,590,573 | 68,820 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,619,279 | 67,743 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $12,539,588 | 68,861 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $11,632,048 | 75,060 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,957,996 | 73,514 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $9,751,083 | 72,375 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $10,003,495 | 62,769 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,144,098 | 62,769 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,363,029 | 54,862 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,353,652 | 54,542 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,836,778 | 54,511 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $7,586,462 | 56,030 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $6,063,264 | 56,209 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $6,300,518 | 55,935 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $6,118,434 | 56,537 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,946,074 | 55,493 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,873,157 | 55,636 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $5,490,520 | 55,923 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,277,535 | 56,143 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||